Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Ductal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05209074
What this trial is testing

Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Cancer
Case Comprehensive Cancer Center 16
Early research (Phase 1)Looking for participantsNCT07024615
What this trial is testing

ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc. 25
Not applicableStudy completedNCT03772756
What this trial is testing

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
First People's Hospital of Hangzhou 38
Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Large-scale testing (Phase 3)Looking for participantsNCT07252232
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma+2 more
Revolution Medicines, Inc. 500
Testing effectiveness (Phase 2)Looking for participantsNCT06060405
What this trial is testing

Durvalumab and Oleclumab in Resectable PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 22
Not applicableUnknownNCT05584852
What this trial is testing

Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Skeletal Muscle RadiodensityMyosteatosisScr/CysC Ratio+1 more
The Affiliated Hospital of Qingdao University 240
Not applicableWithdrawnNCT01911416
What this trial is testing

A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University of Utah
Large-scale testing (Phase 3)Looking for participantsNCT04969731
What this trial is testing

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
GC Cell Corporation 408
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477418
What this trial is testing

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic CancerPancreatic Neoplasms
University of Vermont 10
Very early researchLooking for participantsNCT04005690
What this trial is testing

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more
OHSU Knight Cancer Institute 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06361030
What this trial is testing

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Cancer Non-resectablePancreatic Ductal Adenocarcinoma, PDAC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableUnknownNCT05489458
What this trial is testing

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

Who this might be right for
Carcinoma, Pancreatic Ductal
BUSQUETS, JULI 100
Not applicableActive Not RecruitingNCT07157605
What this trial is testing

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Who this might be right for
Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 94
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Not applicableLooking for participantsNCT06388967
What this trial is testing

Pancreatic Cancer Detection Consortium

Who this might be right for
Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more
City of Hope Medical Center 2,000
Early research (Phase 1)Active Not RecruitingNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Not applicableLooking for participantsNCT06287749
What this trial is testing

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Who this might be right for
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more
University Hospital, Montpellier 37
Not applicableUnknownNCT04915417
What this trial is testing

Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 30
Next Page